European Commission Consults Public On Proposal To Revise Cosmetics Regulation

The Commission specifically cites “lack of specific provisions for endocrine disruptors, the applicability of a generic approach on risk management (GRA) for other harmful substances, the potential diverging opinions from committees responsible for the assessment of chemicals, and the lack of coherence between legislations on the definition of nanomaterials” as points of interest.

• Source: Alamy

Stakeholders have until 21 June to weigh in on the European Commission’s plan to revise the EU Cosmetic Products Regulation in line with Green Deal objectives.

More from Europe

More from Geography

Alliance Pharma Set To Be Snapped Up By Private Equity

 
• By 

Offer valuing struggling UK consumer health player Alliance at £350m has the backing of the company's board of directors.

EU Probiotics Deadlock: Ombudsman Finds ‘No Maladministration’ By The Commission

 
• By 

In response to an IPA Europe complaint, European Ombudsman Emily O’Reilly finds that the Commission’s interpretation of EU food legislation in relation to probiotics is “reasonable and in line with the main goal of this legislation, which is to ensure a high level of consumer protection.”

Haleon Completes Deal To Grow Stake In China JV

 
• By 

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.